Gillian Sandler has over two decades of experience as a Chairman & CEO, board member, corporate strategist, advisor, investor, entrepreneur, and Equity Research analyst.
She has also provided support to and collaborated with countless think tanks, scientists, inventors, investment funds, non-profits, entrepreneurs, and family investments & causes in the U.S. and internationally.
She currently serves as a member of:
Lead investor and Board Member in AZTherapies, a leading clinical stage biopharma company focused on advancing treatments for neuroinflammation and neurodegeneration. The company’s Phase III clinical trial is fully enrolled and the first in the market to focus on treating neuroinflammation and microglia [the brain’s immune cells] to prevent, slow or delay progression of early stage Alzheimer’s.
Lead investor and Board Member in Mymee, a company that developed a pioneering platform for personalized diagnosis and treatment of patients suffering from autoimmune diseases; ranging from Lupus to “n of 1 cases” that have morphed into an unclassified or mixed diagnosis in the autoimmune family.
She previously was a lead investor and served on the Board of Directors of Invicro [sold to Konica Minolta 4Q/17) after having co-led the financing for the acquisition of Molecular Neuro Imaging (MNI). Invicro is the leader in providing the most advanced imaging solutions to life sciences companies from discovery research through Phase 3 clinical trials. Their innovative imaging work in the field of Alzheimer’s and cancer immunotherapy is critical to reducing the cost and time to get effective new treatments to market safely.
She currently serves on the Board of Trustees of the Columbia Zuckerman Mind, Brain, Behavior Institute. Her first role in helping to advance research and care in the field of brain health was 15 years ago serving on the Board of the Pediatric Brain Injury (PBI) Program, U of Miami School of Medicine (the pediatric arm of The Miami Project) a leading center for the prevention, research, and rehabilitation of children with severe brain injury.
She was previously the CEO & Chairman of Todobebe, Inc from 2001 to 2012 (sold to Entravision (EVC) 2012). In this role, she received the 1st Pioneer Award for Changing Health Disparity among underserved populations by former U.S. Surgeon General Richard Carmona, and was nominated as a top CEO of Hispanic Media companies by Hispanic Ad (2010 & ‘11).
Under her leadership, Todobebe grew from the first global website for Spanish & Portuguese speaking parents expecting and raising children 0-5 years old, to a household consumer brand in the Hispanic markets across Broadcast TV (over 250 episodes of “Todobebe” and “Viva La Familia”), Digital, Radio, Events, Marketing, Research, Mobile, Publishing, and Licensing, anchored by a half a million member mom’s club, and multi-year partnerships with the largest TV, retail and consumer brands serving the Hispanic market [Univision, Telemundo-NBC, Televisa, Walmart, and Procter & Gamble].
She also served from 2001 to 2008 on the Board of Directors of Medcenter Solutions, when it was the leading CRM Pharmaceutical marketing and Continuing Medical Education Company serving Brazil, Argentina and Mexico.
She was previously the co-Founder & first CEO of Wallaware, Inc, a next generation mobile software company with a platform and API and simple SDK to enable telco’s to securely control, manage, analyze, develop use cases, drive apps development, and monetize consumer and enterprise mobile data use. During her tenure it was ranked as a top-4 emerging mobile technology company in Europe by Tornado Insider (‘00), and was selected by IBM as its first “Blue Light” case study supporting emerging mobile tech companies (‘01).
She was also a Strategist with AppNet/CMRC where her role was to advise Fortune 500 corporations across consumer products, healthcare, finance, media and publishing on how to leverage their assets to prepare for long term growth in a rapidly changing technology, telecom & media landscape – build/buy/partner, 10 year business plan development, deal structures, valuation, negotiation.
She was also an equity analyst at JPMorgan, on the team that earned the #1 Institutional Investor ranking for the Telecom Industry in Latin America. She covered privatizations and IPOs across the region, and wrote extensively on the future of the emerging wireless industry.
She also worked in JP Morgan Global Credit developing credit ratings and recommendations behind loans to the largest U.S. retailers during a period of rapid industry transition and high number of bankruptcies (1995).
In October 2012 and February 2013 she completed the Executive Programs “FutureMed” and “Singularity” at Singularity University at NASA/Ames in Mountain View California.
At JPMorgan, she completed the Management Services training program, the Equity Research training program, and received her Series 7 and Series 63 certifications.
Gillian received a BA and Certificate for International Relations with a focus on Developing Economies from Wesleyan University (CT), and ran for the University Track & Cross Country teams.
Prior to University, she worked for a semester at JPL/NASA doing programming (IDL) and satellite industry research.